Q4 2020 13F Holders as of 12/31/2020
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
78.4M
-
Number of holders
-
108
-
Total 13F shares, excl. options
-
33.7M
-
Shares change
-
+7.82M
-
Total reported value, excl. options
-
$1.29B
-
Value change
-
+$360M
-
Number of buys
-
84
-
Number of sells
-
-25
-
Price
-
$38.15
Significant Holders of Replimune Group, Inc. - COMMON STOCK (REPL) as of Q4 2020
121 filings reported holding REPL - Replimune Group, Inc. - COMMON STOCK as of Q4 2020.
Replimune Group, Inc. - COMMON STOCK (REPL) has 108 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 33.7M shares
of 78.4M outstanding shares and own 43.02% of the company stock.
Largest 10 shareholders include Omega Fund Management, LLC (5.07M shares), Redmile Group, LLC (3.99M shares), FMR LLC (2.63M shares), PRICE T ROWE ASSOCIATES INC /MD/ (2.63M shares), BlackRock Inc. (2.18M shares), STATE STREET CORP (1.57M shares), VANGUARD GROUP INC (1.4M shares), Corriente Advisors, LLC (1.24M shares), Ensign Peak Advisors, Inc (1.21M shares), and CITADEL ADVISORS LLC (1.16M shares).
This table shows the top 108 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.